The Mirena IUD, cause of pelvic infections?

The Mirena IUD is presented as one of the most comfortable and effective contraceptive methods with fewer side effects. However, like any hormonal contraceptive, it is not without health risks. And although the cases in which the Mirena IUD has presented complications are minimal, we do not want to ignore this relationship that the intrauterine device has with pelvic infections.

What is pelvic inflammatory disease

• Pelvic inflammatory disease is a bacterial infection that can be located in the lining of the uterus, in the ovaries, or in the fallopian tubes. The most frequent causes of this disease are sexually transmitted diseases such as gonorrhea or chlamydia, but there have also been cases of this pelvic inflammation after the insertion of the Mirena IUD.
• With this we do not want to alarm either the users or the possible users of this hormonal intrauterine device, but rather make them aware of the importance of a professional gynecologist who advises the use of the Mirena IUD and inserts it.
• Some of the symptoms of pelvic infection are fatigue, abdominal pain, heavy bleeding, and changes in vaginal discharge. It should be noted that all of them have been considered at some point as side effects of the Mirena IUD. In any case, a reliable and sure diagnosis is needed to start treating this infection.

Removal of the Mirena IUD

It must be taken into account that the consequences of not treating this infection can vary from chronic abdominal pain to infertility, including the risk of an ectopic pregnancy. In any case, the moment the pelvic inflammatory disease is diagnosed, the removal of the Mirena IUD will be necessary. Of course, the removal of the IUD, like its insertion, requires a professional to avoid perforations and other damage to the genital tract. And if you've never used an intrauterine device and have a pelvic infection in your history, your gynecologist may rule out the Mirena IUD as a method of birth control ## How Mirena can be associated with pelvic infections — mechanisms and true risk The existing text above correctly raises the association between intrauterine devices (IUDs) such as Mirena and pelvic infections. To expand on that in practical, evidence-based terms: - The Mirena IUD itself is not a bacterial agent and does not “cause” pelvic inflammatory disease (PID) in the way an infectious organism does. The main mechanistic risk is transient: bacteria can be introduced into the uterine cavity during insertion, particularly if urethral or cervical infection is present at the time of the procedure. - The absolute risk of clinically significant PID after IUD insertion is low in most populations — typically well under 1% in screened, low-risk groups. The incremental increase in PID risk, when it occurs, is concentrated in the first 2–4 weeks after insertion. - Long-term risk of PID with an IUD in place is not meaningfully higher than in comparable women without an IUD. Most later PID events are due to sexually transmitted infections acquired after insertion, not to the IUD itself. - Key biological contributors to infection risk at insertion: - Pre-existing cervicitis (e.g., chlamydia, gonorrhea) that is not detected or treated. - Poor aseptic technique or contamination during insertion (rare when performed by trained clinicians). - Multiple recent sexual partners or other ongoing STI exposure after insertion. - Immunosuppression or diabetes (increase general infection susceptibility). Real-world example: - A 24-year-old patient presents for Mirena insertion. She reports unprotected sex with a new partner three weeks earlier. No STI test was performed before insertion. Ten days after insertion she develops lower abdominal pain and purulent discharge; tests reveal chlamydia. This scenario illustrates entry of an existing, untreated cervical infection into the upper genital tract during or after IUD placement. Practical takeaways for patients and clinicians: - Pre-insertion screening and risk assessment are essential and highly effective at reducing risk. - The clinician performing insertion should follow sterile technique and minimize manipulation of the cervix. - Inform patients that the small increased risk is mostly in the early weeks after insertion; encourage safer sex and timely evaluation for symptoms. ## Risk reduction: pre-insertion screening, counseling, and placement technique (actionable) Actionable checklists and steps every clinician and patient should follow to minimize infection risk: Pre-insertion checklist (clinician): - Take a focused sexual and STI risk history: - Recent new sexual partner(s), multiple partners, prior STIs, or symptoms (discharge, bleeding, dysuria). - Offer or perform point-of-care or lab-based STI testing (nucleic acid amplification tests for chlamydia and gonorrhea) ideally before insertion. If testing results are pending, weigh relative risks; many clinics perform same-day insertion if the patient accepts and is low risk. - Perform a pelvic exam to look for cervicitis or discharge. If cervicitis is present, defer insertion and treat the infection. - Confirm pregnancy status per guidelines (pregnancy is a contraindication to insertion). - Counsel the patient about early PID risk (first 20 days to first month), signs/symptoms to watch for, and the plan if symptoms develop. - Obtain informed consent that documents discussion of rare but serious risks (PID, perforation, expulsion). Insertion technique (clinician): - Use standard aseptic technique — hand hygiene, sterile gloves, sterile instruments. - Consider prophylactic analgesia (NSAID) and cervical priming if cervical stenosis is anticipated (e.g., nulliparous or post-partum patients), but routine antibiotic prophylaxis is not recommended. - Minimize cervical manipulations and excessive traction on the uterus. - If insertion is difficult or painful, consider aborting and re-evaluating; avoid forcing the device. - Confirm string visibility at the end of the procedure and provide the patient with instructions for checking strings at home. Counseling points for patients (what to tell the person getting Mirena): - You may have cramping and light bleeding for a few days after insertion; severe pain or fever is not typical and requires urgent care. - Check the threads at the top of your vagina after your first menses or at 4–6 weeks; if you cannot feel strings, or if you feel the hard plastic of the device, come in for evaluation. - Avoid inserting anything into the vagina (tampons, sex) for the period your clinician recommends (often immediate return to normal activity is acceptable; clarify with your clinician). - If you develop fever, severe pelvic pain, abnormal heavy bleeding, or foul-smelling discharge, seek medical attention immediately. Examples of practical clinic protocols: - Clinic A: Offers same-day insertion for low-risk patients; performs NAAT results at baseline and treats positives promptly if they appear; provides written PID symptom checklist and 24-hour contact. - Clinic B: Screens all patients for chlamydia/gonorrhea; defers insertion until negative results or until the patient completes treatment if positive. For patients interested in supplies (pain relief or self-test kits) see our [shop](/shop). ## Managing suspected or confirmed PID with an IUD in place — evidence-based, step-by-step When a patient with an IUD presents with suspected PID, immediate, evidence-based action is needed. The following are practical and current recommendations grounded in clinical guidance used in gynecology practice. Initial assessment (urgent): - Obtain a targeted history: timing in relation to insertion, sexual history, contraceptive history, current symptoms (fever, chills, abdominal or pelvic pain, abnormal discharge, bleeding). - Perform vital signs and abdominal/pelvic exam, noting cervical motion tenderness, uterine or adnexal tenderness, visible purulent discharge. - Obtain tests: pregnancy test, NAAT for chlamydia/gonorrhea, vaginal swab for microscopy/culture if available, CBC if febrile/inpatient, and consider pelvic ultrasound to evaluate for tubo-ovarian abscess. Immediate management (outpatient vs inpatient decision): - Outpatient therapy is appropriate for patients who are clinically stable, can tolerate oral intake, and do not have severe illness, abscess, or pregnancy. - Typical outpatient antibiotic regimen (examples following common guideline frameworks — always consult local protocols): - A single dose intramuscular cephalosporin (for example, ceftriaxone 500 mg IM once; dose adjustments for weight per local guidance) PLUS - Doxycycline 100 mg orally twice daily for 14 days. - Add metronidazole 500 mg twice daily for 14 days if anaerobic coverage is indicated (e.g., severe cervical infection or suspected bacterial vaginosis). - In severe cases or when hospitalization is needed: IV cefoxitin or cefotetan plus doxycycline is commonly used; surgical consultation if abscess or peritonitis suspected. IUD removal vs retention — practical guidance: - Older sources and some clinical opinions recommended removal of IUD with any PID diagnosis. Contemporary guidance is nuanced: - If the patient responds clinically to appropriate antibiotics within 48–72 hours, the IUD may be left in place. This allows continued effective contraception and avoids replacement procedures. - Remove the IUD if there is: - No clinical improvement in 48–72 hours. - Severe illness necessitating hospitalization. - Tubo-ovarian abscess that is not responding or requires drainage. - Pregnancy. - Document shared decision-making: explain pros/cons of removal vs retention, and the plan for follow-up. - Example: A 31-year-old with Mirena inserted 6 months earlier presents with PID symptoms; NAAT positive for chlamydia. She is started on outpatient antibiotics and improves within 48 hours — the Mirena is retained, and follow-up NAAT and fertility counseling are provided. Follow-up and partner management: - Arrange close follow-up within 48–72 hours to confirm clinical response. - Treat sexual partners as per STI management guidelines (for chlamydia/gonorrhea) to prevent reinfection. - Repeat STI testing at 3 months may be reasonable depending on local guidance and initial organism. When to escalate care: - Worsening pain, persistent fever, signs of systemic infection, inability to tolerate oral meds, concern for abscess, or pregnancy are triggers for urgent specialty care and likely removal of the IUD. Practical tips for clinicians: - Have a written PID protocol in your clinic that includes algorithms for IUD management. - Ensure patients have direct access to nursing triage and urgent appointments in the first 48–72 hours after starting treatment. - Keep standardized patient information leaflets that explain symptoms and when to return. ## Real examples and practical advice for patients 1. Example — Early post-insertion PID: - Patient: 27-year-old nulliparous woman, Mirena inserted at routine visit. No STI testing performed. Two weeks later she develops fever and severe lower abdominal pain. - Action taken: On exam, she had cervical motion tenderness and purulent discharge. NAAT positive for gonorrhea. She was admitted, given IV antibiotics, Mirena removed due to severe infection and need for inpatient management. She recovered after 72 hours and was discharged with oral antibiotics. - Practical takeaways: If you have risk factors for STIs, request testing before insertion; if you develop fever or severe pain after insertion, seek emergency care. 2. Example — Mild PID months after insertion: - Patient: 34-year-old with Mirena for 2 years, low-risk sexual history, presents with mild pelvic pain and increased discharge. NAAT positive for chlamydia. - Action taken: Treated as outpatient with doxycycline and ceftriaxone; Mirena retained because she improved rapidly and wished to continue the device. - Practical takeaways: Not all PID requires removal of the IUD; rapid improvement with antibiotics often allows retention. Practical advice checklist for patients considering Mirena: - Ask your clinician to document STI screening or explain why same-day insertion is still safe for you. - Learn to check strings and report any changes promptly. - Keep emergency contact details for your clinic and know where to go for urgent pelvic pain. - If you have a history of recurrent STIs or pelvic infections, discuss alternative contraception options or additional monitoring. For further reading on contraception choices and safety, see our [related topic](/blog). ## FAQ ## FAQ ### Can Mirena actually cause pelvic inflammatory disease? No — Mirena itself is not an infectious agent and does not directly cause PID. The primary risk is introduction of bacteria into the upper genital tract during insertion if a cervical infection is present. Most PID cases temporally related to IUDs occur in the early weeks after insertion and are uncommon if appropriate screening and aseptic insertion practices are followed. ### How common is PID after Mirena insertion? In properly screened populations the incidence is low — generally well under 1% in routine practice. The small increased risk is concentrated in the first few weeks after insertion. The long-term risk of PID with an IUD in place is similar to that of women not using an IUD when sexual behavior and STI exposure are accounted for. ### If I develop PID, do I have to have my Mirena removed? Not always. Current practice allows retention of an IUD if the patient responds clinically to appropriate antibiotic therapy within 48–72 hours. Removal is recommended for severe infection requiring hospitalization, lack of improvement on antibiotics, pregnancy, or when a tubo-ovarian abscess is present. Decisions should be individualized with shared decision-making between clinician and patient. ### What should I do before getting Mirena to reduce my infection risk? Practical steps: - Disclose your sexual history and any symptoms to your clinician. - Request STI testing (chlamydia and gonorrhea NAAT) before insertion if you have risk factors. - If cervicitis or an STI is detected, complete treatment before insertion. - Ensure the procedure is done by a trained clinician using sterile technique. - Learn the signs of PID and have a plan for urgent evaluation if symptoms occur. ### I had PID in the past. Can I still get Mirena? Possibly, but it depends on the timing and severity of past infections. If you had PID that resolved and you have no ongoing STI risk, Mirena may be an appropriate option. If you have recurrent PID or unresolved pelvic infection, your gynecologist may recommend delaying or choosing another method. Discuss your history in detail with your clinician — sometimes additional imaging or testing is advised before insertion. --- Category: Health Issues Topic: The Mirena IUD, cause of pelvic infections? References and clinic resources (practical): - Clinic protocol template: include pre-insertion STI screen, consent form language, and 48–72 hour follow-up appointment option. - Patient handout suggestion: “When to seek urgent care after IUD insertion” — include fever, severe pain, heavy bleeding, foul discharge. - Supplies and aids: consider supplying NSAIDs (ibuprofen 400–600 mg for cramp relief, as tolerated), a mirror and instructions for checking strings, and reliable STI self-testing kits available through our [shop](/shop). If you want, I can: - Provide a downloadable clinic checklist for pre-insertion screening and counseling. - Draft a patient-facing leaflet you can hand out at insertion visits. - Summarize local guideline recommendations (e.g., CDC, WHO) relevant to your country or practice setting.